{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:22:26Z","timestamp":1780384946907,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T00:00:00Z","timestamp":1683417600000},"content-version":"am","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jiac.2022.03.015","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T01:30:36Z","timestamp":1648171836000},"page":"934-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-8378","authenticated-orcid":false,"given":"Ayano","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.03.015_bib1","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-based COVID-19 vaccines","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2022.03.015_bib2","doi-asserted-by":"crossref","first-page":"2100634","DOI":"10.2807\/1560-7917.ES.2021.26.28.2100634","article-title":"Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England","volume":"26","author":"Powell","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jiac.2022.03.015_bib3","doi-asserted-by":"crossref","first-page":"101595","DOI":"10.1016\/j.pmedr.2021.101595","article-title":"Early solicited adverse events following the BNT162b2 mRNA vaccination, a population survey from Saudi Arabia","volume":"24","author":"Almohaya","year":"2021","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.jiac.2022.03.015_bib4","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3346\/jkms.2021.36.e115","article-title":"Adverse reactions following the first dose of ChAdOx1 nCoV-19 vaccine and BNT162b2 vaccine for healthcare workers in South Korea","volume":"36","author":"Bae","year":"2021","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.jiac.2022.03.015_bib5","first-page":"1","article-title":"Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021","author":"Ossato","year":"2021","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.jiac.2022.03.015_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/biology10080752","article-title":"Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers","volume":"10","author":"Klugar","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.jiac.2022.03.015_bib7","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jiac.2022.03.015_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study","volume":"14","author":"El-Shitany","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jiac.2022.03.015_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jiac.2021.09.009","article-title":"Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers in Japan","volume":"28","author":"Saita","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.03.015_bib10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/vaccines9101149","article-title":"Association between immunoglobulin G levels and adverse effects following vaccination with the BNT162b2 vaccine among Japanese healthcare workers","volume":"9","author":"Otani","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jiac.2022.03.015_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/trstmh\/tru167","article-title":"Sex-based differences in immune function and responses to vaccination","volume":"109","author":"Klein","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jiac.2022.03.015_bib12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jiac.2022.03.015_bib13","first-page":"198","article-title":"The influence of sex and gender on immunity, infection and vaccination","volume":"52","author":"Ruggieri","year":"2016","journal-title":"Ann Ist Super Sanita"},{"key":"10.1016\/j.jiac.2022.03.015_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and gender differences in the outcomes of vaccination over the life course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jiac.2022.03.015_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.it.2021.02.003","article-title":"The dual nature of type-I interferons in SARS-CoV-2 induced inflammation","volume":"42","author":"King","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jiac.2022.03.015_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.7326\/M20-1941","article-title":"Sex and gender differences in health: what the COVID-19 pandemic can teach us","volume":"173","author":"Spagnolo","year":"2020","journal-title":"Ann Intern Med"},{"issue":"70","key":"10.1016\/j.jiac.2022.03.015_bib17","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm7038e1","article-title":"Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions - United States, March-August 2021","volume":"24","author":"Self","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22000940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22000940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:54Z","timestamp":1761159894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1341321X22000940"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.03.015","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}